|
AU3642795A
(en)
|
1994-09-27 |
1996-04-19 |
Merck & Co., Inc. |
Endothelin receptor antagonists for the treatment of emesis
|
|
US5939431A
(en)
*
|
1996-06-20 |
1999-08-17 |
Schering Corporation |
Naphthyridines which affect IL-4 and G-CSF
|
|
AR038955A1
(es)
|
1996-12-05 |
2005-02-02 |
Amgen Inc |
Compuestos de pirimidinona y piridona sustituidos y metodos para su uso
|
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
WO2003087044A2
(en)
|
2002-04-09 |
2003-10-23 |
7Tm Pharma A/S |
Novel carboxamide compounds for use in mch receptor related disorders
|
|
EP2172460A1
(en)
|
2002-11-01 |
2010-04-07 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of JAK and other protein kinases
|
|
CA2514733A1
(en)
|
2003-02-28 |
2004-09-16 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
|
US20040204422A1
(en)
|
2003-04-14 |
2004-10-14 |
Abbott Gmbh & Co. Kg. |
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
|
|
SE0301654D0
(sv)
*
|
2003-06-05 |
2003-06-05 |
Astrazeneca Ab |
Novel compounds
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
JPWO2005040135A1
(ja)
|
2003-10-24 |
2007-03-08 |
小野薬品工業株式会社 |
抗ストレス薬およびその医薬用途
|
|
PE20060285A1
(es)
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
MXPA06012130A
(es)
|
2004-04-20 |
2007-01-31 |
Transtech Pharma Inc |
Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina.
|
|
FR2874011B1
(fr)
|
2004-08-03 |
2007-06-15 |
Sanofi Synthelabo |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
ES2343640T3
(es)
|
2004-08-12 |
2010-08-05 |
Amgen Inc. |
Bisaril-sulfonamidas.
|
|
JP5414990B2
(ja)
|
2004-10-04 |
2014-02-12 |
エフ．ホフマン−ラ ロシュ アーゲー |
糖尿病のための１１−β阻害剤としてのアルキルピリジン
|
|
EP1666467A1
(en)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
11Beta-HSD1 Inhibitors
|
|
SE0402735D0
(sv)
|
2004-11-09 |
2004-11-09 |
Astrazeneca Ab |
Novel compounds
|
|
WO2006106423A2
(en)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
|
|
CA2620179C
(en)
|
2005-08-16 |
2013-10-29 |
Icagen, Inc. |
Inhibitors of voltage-gated sodium channels
|
|
KR20080031460A
(ko)
|
2005-08-25 |
2008-04-08 |
에프. 호프만-라 로슈 아게 |
Ｐ38 ｍａｐ 키나아제 저해제 및 이의 사용 방법
|
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
|
WO2007129044A1
(en)
|
2006-05-03 |
2007-11-15 |
Astrazeneca Ab |
Thiazole derivatives and their use as anti-tumour agents
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
ATE496905T1
(de)
|
2006-07-14 |
2011-02-15 |
Chemocentryx Inc |
Triazolyl-pyridyl-benzolsulfonamide als ccr2- oder ccr9-modulatoren zur behandlung von atherosklerose
|
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
|
EP2054056A4
(en)
|
2006-08-16 |
2010-08-25 |
J David Gladstone Inst A Testa |
SMALL MOLECULAR INHIBITORS OF KYNURENINE-3-MONOOXYGENASE
|
|
CA2662091A1
(en)
|
2006-09-08 |
2008-03-13 |
Novartis Ag |
N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
|
|
WO2008033455A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
|
|
MX2009011025A
(es)
|
2007-04-11 |
2010-01-25 |
Canbas Co Ltd |
Compuestos con actividad anticancer.
|
|
US20090209536A1
(en)
|
2007-06-17 |
2009-08-20 |
Kalypsys, Inc. |
Aminoquinazoline cannabinoid receptor modulators for treatment of disease
|
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
|
JP2011500823A
(ja)
|
2007-10-22 |
2011-01-06 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
Ｐｉ３キナーゼ阻害物質としてのピリドスルホンアミド誘導体
|
|
CA2714232A1
(en)
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
|
EP2297097A2
(en)
|
2008-06-11 |
2011-03-23 |
Irm Llc |
Compounds and compositions useful for the treatment of malaria
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
WO2010100475A1
(en)
|
2009-03-02 |
2010-09-10 |
Astrazeneca Ab |
Hydroxamic acid derivatives as gram-negative antibacterial agents
|
|
EP2421368A4
(en)
*
|
2009-04-20 |
2013-01-09 |
Inst Oneworld Health |
COMPOUNDS, COMPOSITIONS AND METHODS FOR PYRIDAZINE SULFONAMIDE DERIVATIVES
|
|
EP2253617A1
(de)
|
2009-05-20 |
2010-11-24 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
|
ES2626601T3
(es)
|
2010-06-28 |
2017-07-25 |
Bayer Intellectual Property Gmbh |
Compuestos heterocíclicos como pesticidas
|
|
WO2012004293A2
(de)
|
2010-07-08 |
2012-01-12 |
Bayer Cropscience Ag |
Insektizide und fungizide wirkstoffkombinationen
|
|
JP2014500303A
(ja)
|
2010-12-22 |
2014-01-09 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としての置換ピリジン
|
|
WO2012125904A1
(en)
|
2011-03-17 |
2012-09-20 |
The Trustees Of The University Of Pennsylvania |
Mutation mimicking compounds that bind to the kinase domain of egfr
|
|
ES2882807T3
(es)
*
|
2011-09-16 |
2021-12-02 |
Novartis Ag |
Heterociclil carboxamidas N-sustituidas
|
|
EP2822931B1
(en)
*
|
2012-03-09 |
2017-05-03 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
|
DK2888251T3
(da)
|
2012-08-21 |
2019-07-29 |
Peter Maccallum Cancer Inst |
Perforinhæmmende benzensulfonamidforbindelser, fremstilling og anvendelser deraf
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
US20140371238A1
(en)
|
2013-03-13 |
2014-12-18 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
US20170002011A1
(en)
|
2013-12-23 |
2017-01-05 |
Norgine B.V. |
Benzene sulfonamides as ccr9 inhibitors
|
|
CA2942387A1
(en)
*
|
2014-03-13 |
2015-09-17 |
Proteostasis Therapeutics, Inc. |
Compounds, compositions and methods of increasing cftr actvity
|
|
RS60906B1
(sr)
|
2014-10-06 |
2020-11-30 |
Vertex Pharma |
Modulatori regulatora transmembranske provodljivosti za cističnu fibrozu
|
|
CN104844566B
(zh)
|
2014-12-12 |
2018-05-18 |
合肥中科普瑞昇生物医药科技有限公司 |
一种新型结构的激酶抑制剂
|
|
KR20180029204A
(ko)
|
2015-06-02 |
2018-03-20 |
애브비 에스.에이.알.엘. |
치환된 피리딘 및 사용 방법
|
|
US9981945B2
(en)
*
|
2015-10-07 |
2018-05-29 |
NuBridge BioSciences |
Pyrimidine derivatives as CFTR modulators
|
|
GB201602527D0
(en)
*
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
ES2946970T3
(es)
|
2016-03-31 |
2023-07-28 |
Vertex Pharma |
Regulador de conductancia transmembrana de moduladores de fibrosis quística
|
|
TW201811766A
(zh)
*
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|